tryptophan has been researched along with substance p in 54 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (9.26) | 18.7374 |
1990's | 12 (22.22) | 18.2507 |
2000's | 17 (31.48) | 29.6817 |
2010's | 19 (35.19) | 24.3611 |
2020's | 1 (1.85) | 2.80 |
Authors | Studies |
---|---|
Werle, E | 1 |
Felder, M | 1 |
Koegel, A; Mangel, AW | 1 |
Dun, NJ; Kiraly, M; Ma, RC | 1 |
D'Orléans-Juste, P; Dion, S; Drapeau, G; Escher, E; Mizrahi, J; Regoli, D | 1 |
Ber, E; Cascieri, MA; Macleod, AM; Merchant, KJ; Sadowski, S; Shiao, LL; Strader, CD; Swain, CJ; Underwood, D; Yu, H | 1 |
Chan, MY; Tang, F | 1 |
Ber, E; Brookfield, F; Casiceri, MA; Kelleher, F; MacLeod, AM; Merchant, KJ; Owens, AP; Sadowski, S; Stevenson, G; Swain, CJ | 1 |
Barrow, CJ; Brownell, JE; Gillum, AM; Hong, A; Houck, DR; Sedlock, DM | 1 |
Cummings, J; Langdon, SP; MacLellan, A; Rozengurt, E; Smyth, JF | 1 |
Cascieri, MA; Fong, TM; Hardwicke, S; Lewis, RT; MacIntyre, DE; MacLeod, AM; Merchant, KJ; Metzger, JM; Sadowski, S; Shepheard, S | 1 |
Isobe, T; Okuyama, T; Shinoda, T; Yamaki, S | 1 |
Field, MJ; Hughes, J; Kuo, BS; Naylor, RJ; Singh, L; Suman-Chauhan, N; Tuladhar, BR; Wright, DS | 1 |
Boudon, A; Fauchère, JL; Jacoby, E; Kucharczyk, N; Michel, A | 1 |
Field, MJ; Gonzalez, MI; Holloman, EF; Hughes, J; Oles, RJ; Singh, L | 1 |
Nowicki, PT | 1 |
Ackenheil, M; Bondy, B; Müller-Bardorff, H; Pongratz, DE; Schwarz, MJ; Späth, M | 1 |
Ganesan, A; Wang, H | 1 |
Hwang, KH; Kuo, HP; Lin, HC; Lu, LC; Wang, CH | 1 |
Cahill, CM; Coderre, TJ | 1 |
Khoo, HE; Low, KS; Sung, JM | 1 |
Bredesen, DE; Castro-Obregón, S; Chen, SF; Del Rio, G; Frankowski, H; Nicholls, DG; Rao, RV; Stoka, V; Swanson, RA; Vesce, S | 1 |
El-Mahmoudy, A; Khalifa, M; Matsuyama, H; Shimizu, Y; Takewaki, T | 1 |
Cernak, I; Cruz, MI; Donkin, JJ; Nimmo, AJ; Vink, R | 1 |
Liu, H; Wang, L; Zhang, G; Zhang, J | 1 |
Howe, HE; Sladek, CD; Somponpun, SJ | 1 |
Gardell, LR; Hruby, VJ; Hunt, SP; King, T; Lai, J; Malan, PT; Ossipov, MH; Porreca, F; Vanderah, TW; Vardanyan, A; Wang, R | 1 |
Inoue, T; Kamei, C; Rahman, MA | 1 |
Hiyama, Y; Ishimura, M; Kataoka, S; Maeda, T; Suda, M | 1 |
Arreola, JL; Chávez, J; Flores-Soto, E; Montaño, LM; Segura, P; Vargas, MH | 1 |
Coveñas, R; González-Moles, MA; Montero, I; Muñoz, M; Robles, MJ; Rosso, M | 1 |
Aguilar, FJ; Esteban, F; González-Moles, MA; Muñoz, M; Redondo, M; Rosso, M | 1 |
Choi, JY; Hanrahan, JW; Ianowski, JP; Wine, JJ | 1 |
Blumbergs, PC; Cernak, I; Donkin, JJ; Nimmo, AJ; Vink, R | 1 |
Bullens, DM; Cadot, P; Callebaut, I; Ceuppens, JL; Hellings, PW; Hens, G; Meyts, I; Nemery, B; Raap, U; Vanaudenaerde, BM; Vanoirbeek, J; Verbinnen, B | 1 |
Dubner, R; Guo, W; Lagraize, SC; Ren, K; Wei, F; Yang, K | 1 |
Coveñas, R; González-Ortega, A; Muñoz, M | 1 |
Barry, CM; den Heuvel, Cv; Helps, SC; Vink, R | 1 |
Helps, SC; Thornton, E; Turner, RJ; Vink, R | 1 |
Janicki, JS; Law, BA; Levick, SP; Li, J; Meléndez, GC; Supowit, SC | 1 |
Ikeda, T; Matsushima, O; Naono-Nakayama, R; Nishimori, T; Sunakawa, N | 1 |
Thornton, E; Vink, R | 1 |
Carthew, HL; Vink, R; Ziebell, JM | 1 |
Corrigan, F; Ghabriel, M; Leonard, A; Van Den Heuvel, C; Vink, R | 1 |
Hayashi, H; Oh-ishi, T; Onaga, T; Shimoda, T | 1 |
Carranza, A; Coveñas, R; González-Ortega, A; Muñoz, M; Robles-Frias, MJ; Rosso, M; Salinas-Martín, MV | 1 |
Bienenstock, J; El Aidy, S; Kleerebezem, M; Kunze, W | 1 |
Chen, T; Ji, W; Li, H; Li, YQ; Pei, LY; Wang, W; Wu, SX; Zhang, MM; Zhang, T | 1 |
Leonard, AV; Thornton, E; Vink, R | 1 |
Almendro, V; Carranza, A; Coveñas, R; Garcia-Recio, S; González-Ortega, A; Muñoz, M; Salinas-Martín, MV | 1 |
Dai, GH; Deng, WT; Guo, XD; Huang, KB; Luo, GQ; Pan, SY; Peng, KR; Qian, NS; Wu, XN; Xiang, W; Yang, HJ; Zhang, T | 1 |
Friedlander, RM; Jiang, J; Li, W; Mao, LL; Sirianni, AC; Sugarbaker, P; Wang, X; Zeng, J; Zhang, X; Zhou, S | 1 |
Aicher, B; Banères, JL; Blayo, AL; Damian, M; Denoyelle, S; Fehrentz, JA; Gagne, D; Günther, E; M'Kadmi, C; Maingot, M; Marie, J; Martinez, J; Mary, S; Müller, G; Sanchez, P; Schmidt, P; Teifel, M | 1 |
Lipiński, PFJ; Matalińska, J | 1 |
2 review(s) available for tryptophan and substance p
Article | Year |
---|---|
[Tissue hormones. A review].
Topics: Acetylcholine; Amines; Aminobutyrates; Angiotensin II; Animals; Bradykinin; Cholecystokinin; Dopamine; Epinephrine; Gastrins; Gastrointestinal Hormones; Histamine; Hormones; Kallidin; Kallikreins; Norepinephrine; Peptides; Prostaglandins; Renin; Secretin; Serotonin; Substance P; Tryptophan; Vasopressins | 1968 |
[The fibrositis syndrome (author's transl)].
Topics: Adult; Behavior Therapy; Chlorpromazine; Edema; Endorphins; Female; Fibromyalgia; Humans; Male; Middle Aged; Neurotic Disorders; Obesity; Pain; Pain Management; Sleep Wake Disorders; Substance P; Syndrome; Tryptophan | 1980 |
52 other study(ies) available for tryptophan and substance p
Article | Year |
---|---|
Effects of peptides on gastric emptying.
Topics: Animals; Gastric Emptying; Male; Neurotensin; Phenylalanine; Rats; Sincalide; Substance P; Tryptophan; Vasoactive Intestinal Peptide | 1984 |
Evidence for a serotonin-mediated slow excitatory potential in the guinea-pig coeliac ganglia.
Topics: Action Potentials; Animals; Calcium; Cell Membrane; Cyproheptadine; Fluoxetine; Ganglia, Sympathetic; Guinea Pigs; In Vitro Techniques; Magnesium; Membrane Potentials; Neurons; Parasympatholytics; Serotonin; Substance P; Tryptophan | 1984 |
A substance P antagonist not containing D-tryptophan.
Topics: Animals; Cricetinae; Dogs; Guinea Pigs; Ileum; In Vitro Techniques; Peptide Fragments; Rats; Substance P; Tryptophan; Urinary Bladder | 1984 |
Characterization of the interaction of N-acyl-L-tryptophan benzyl ester neurokinin antagonists with the human neurokinin-1 receptor.
Topics: Amino Acid Sequence; Animals; Binding Sites; Binding, Competitive; CHO Cells; Cricetinae; Histidine; Humans; Inositol Phosphates; Iodine Radioisotopes; Kinetics; Models, Molecular; Molecular Conformation; Mutagenesis, Site-Directed; Neurokinin-1 Receptor Antagonists; Protein Conformation; Quinuclidines; Rats; Receptors, Neurokinin-1; Structure-Activity Relationship; Substance P; Transfection; Tryptophan | 1994 |
Brain cholecystokinin octopeptide (CCK-8) concentrations: effect of tryptophan and other serotonergic agents.
Topics: Animals; Brain Chemistry; Corpus Striatum; Cyproheptadine; Drug Interactions; Dynorphins; Hippocampus; Hydroxyindoleacetic Acid; Hypothalamus; Imipramine; Male; Proglumide; Rats; Serotonin; Serotonin Receptor Agonists; Sincalide; Substance P; Tryptophan | 1994 |
Identification of L-tryptophan derivatives with potent and selective antagonist activity at the NK1 receptor.
Topics: Acylation; Amino Acid Sequence; Animals; CHO Cells; Computer Simulation; Cricetinae; Dermatitis, Contact; Guinea Pigs; Humans; Male; Models, Molecular; Molecular Conformation; Molecular Sequence Data; Molecular Structure; Neurokinin-1 Receptor Antagonists; Receptors, Neurokinin-1; Recombinant Proteins; Structure-Activity Relationship; Substance P; Tryptophan | 1994 |
WIN 64821, a novel neurokinin antagonist produced by an Aspergillus sp. I. Fermentation and isolation.
Topics: Aspergillus; Astrocytoma; Binding Sites; Chromatography, High Pressure Liquid; Culture Media; Fermentation; Humans; Indoles; Piperazines; Spectrometry, Mass, Fast Atom Bombardment; Substance P; Tryptophan; Tumor Cells, Cultured | 1994 |
Determination of two neuropeptide growth factor antagonists, [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-substance P and [Arg6,D-Trp7,9,N-MePhe8]- substance P(6-11), by high-performance liquid chromatography with electrochemical detection.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Chromatography, High Pressure Liquid; Electrochemistry; Growth Inhibitors; Humans; Mice; Mice, Nude; Molecular Sequence Data; Neoplasm Transplantation; Peptide Fragments; Substance P; Tryptophan | 1994 |
Synthesis and biological evaluation of NK1 antagonists derived from L-tryptophan.
Topics: Amines; Amino Acid Sequence; Animals; Binding Sites; Biphenyl Compounds; Cardiovascular System; CHO Cells; Cricetinae; Esters; Extravasation of Diagnostic and Therapeutic Materials; Female; Ferrets; Guinea Pigs; Heterocyclic Compounds; Humans; Hypnotics and Sedatives; Male; Molecular Sequence Data; Neurokinin-1 Receptor Antagonists; Piperidines; Receptors, Neurokinin-1; Solubility; Structure-Activity Relationship; Substance P; Tryptophan | 1995 |
Reversed-phase liquid chromatography on a microspherical carbon column at high temperature.
Topics: Amino Acid Sequence; Amino Acids; Angiotensin I; Carbon; Chromatography, High Pressure Liquid; Drug Stability; Hot Temperature; Hydrogen-Ion Concentration; Microspheres; Molecular Sequence Data; Substance P; Tryptophan | 1996 |
The tachykinin NK1 receptor antagonist PD 154075 blocks cisplatin-induced delayed emesis in the ferret.
Topics: Animals; Antiemetics; Antineoplastic Agents; Behavior, Animal; Brain; CHO Cells; Cisplatin; Cricetinae; Dogs; Female; Ferrets; Gerbillinae; Guinea Pigs; Humans; Male; Mice; Neurokinin-1 Receptor Antagonists; Rats; Rats, Wistar; Sensitivity and Specificity; Sheep; Substance P; Swine; Time Factors; Tryptophan; Vomiting | 1997 |
A structural rationale for the design of water soluble peptide-derived neurokinin-1 antagonists.
Topics: Animals; Biphenyl Compounds; Dipeptides; Drug Design; Humans; In Vitro Techniques; Indoles; Models, Chemical; Models, Molecular; Molecular Mimicry; Neurokinin-1 Receptor Antagonists; Peptides; Rats; Solubility; Substance P; Tetrazoles; Tryptophan; Water | 1997 |
Evaluation of PD 154075, a tachykinin NK1 receptor antagonist, in a rat model of postoperative pain.
Topics: Anesthetics; Animals; Excitatory Amino Acid Antagonists; Isoflurane; Male; Pain Threshold; Pain, Postoperative; Pentobarbital; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Substance P; Tryptophan | 1998 |
Postnatal changes in gut hemodynamics: a possible role for substance P.
Topics: Animals; Animals, Newborn; Endothelium, Vascular; Hemodynamics; Intestines; Kinetics; Mesenteric Arteries; Muscle Denervation; Muscle Relaxation; Neurokinin-1 Receptor Antagonists; omega-N-Methylarginine; Oxygen Consumption; Substance P; Swine; Tryptophan; Vascular Resistance | 1998 |
Relationship of substance P, 5-hydroxyindole acetic acid and tryptophan in serum of fibromyalgia patients.
Topics: Adult; Biomarkers; Female; Fibromyalgia; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Pain; Sleep; Substance P; Tryptophan | 1999 |
Total synthesis of the fumiquinazoline alkaloids: solution-phase studies.
Topics: Alkaloids; Antineoplastic Agents; Fungi; ortho-Aminobenzoates; Quinazolines; Substance P; Tryptophan | 2000 |
Lipopolysaccharide enhances substance P-mediated neutrophil adherence to epithelial cells and cytokine release.
Topics: CD18 Antigens; Cell Adhesion; Epithelial Cells; Humans; In Vitro Techniques; Interleukin-1; Lipopolysaccharides; Lung; Macrophage-1 Antigen; Neurokinin-1 Receptor Antagonists; Neutrophils; RNA, Messenger; Serine Proteinase Inhibitors; Substance P; Tryptophan; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2000 |
Attenuation of hyperalgesia in a rat model of neuropathic pain after intrathecal pre- or post-treatment with a neurokinin-1 antagonist.
Topics: Animals; Cold Temperature; Disease Models, Animal; Hyperalgesia; Injections, Spinal; Male; Neurokinin-1 Receptor Antagonists; Nociceptors; Physical Stimulation; Rats; Rats, Long-Evans; Sciatica; Substance P; Tryptophan | 2002 |
Characterization of the mechanism underlying stonustoxin-mediated relaxant response in the rat aorta in vitro.
Topics: Animals; Aorta; Drug Interactions; Enzyme Inhibitors; Fish Venoms; Male; Neurokinin-1 Receptor Antagonists; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; Substance P; Thiazines; Tryptophan; Vasodilation | 2002 |
A ligand-receptor pair that triggers a non-apoptotic form of programmed cell death.
Topics: Animals; Annexin A5; Apoptosis; Caspase Inhibitors; Caspases; Cell Size; Cells, Cultured; Enzyme Inhibitors; Epithelial Cells; Fetus; Humans; Immunohistochemistry; Kidney; Microscopy, Electron; Neurokinin-1 Receptor Antagonists; Neurons; Piperidines; Prosencephalon; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Substance P; Tryptophan | 2002 |
Tachykinins mediate non-adrenergic, non-cholinergic excitatory neurotransmission to the hamster ileum via NK1 and NK2 receptors.
Topics: Animals; Autonomic Agents; Benzamides; Cricetinae; Dose-Response Relationship, Drug; Electric Stimulation; Ileum; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Neurokinin A; Neurokinin-1 Receptor Antagonists; Neuromuscular Junction; NG-Nitroarginine Methyl Ester; Piperidines; Receptors, Neurokinin-1; Receptors, Neurokinin-2; Substance P; Synaptic Transmission; Tryptophan | 2003 |
A substance P antagonist increases brain intracellular free magnesium concentration after diffuse traumatic brain injury in rats.
Topics: Animals; Brain Injuries; Homeostasis; Magnesium; Magnesium Deficiency; Magnetic Resonance Spectroscopy; Male; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Substance P; Tryptophan | 2004 |
Substance P promotes sleep in the ventrolateral preoptic area of rats.
Topics: 3-Mercaptopropionic Acid; Animals; Electroencephalography; Electromyography; Estrenes; Male; Microinjections; Neurokinin-1 Receptor Antagonists; Phosphodiesterase Inhibitors; Polysomnography; Preoptic Area; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Sleep; Substance P; Tryptophan; Wakefulness | 2004 |
Role of neurokinin 3 receptors in supraoptic vasopressin and oxytocin neurons.
Topics: Acetates; Animals; Catecholamines; Cell Compartmentation; Cell Nucleus; Cytoplasm; Endosomes; Hydralazine; Hypotension; Hypothalamo-Hypophyseal System; Hypothalamus, Anterior; Male; Microinjections; Microscopy, Confocal; Neurons; Oxytocin; Peptide Fragments; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Receptors, Neurokinin-1; Receptors, Neurokinin-3; Substance P; Tachykinins; Transcription, Genetic; Tryptophan; Vasopressins | 2004 |
Role of NK-1 neurotransmission in opioid-induced hyperalgesia.
Topics: Animals; Cell Count; Drug Interactions; Hot Temperature; Hyperalgesia; Immunohistochemistry; Male; Mice; Mice, Knockout; Morphine; Narcotics; Neurokinin-1 Receptor Antagonists; Pain Measurement; Protein Transport; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Neurokinin-1; Spinal Cord; Substance P; Synaptic Transmission; Time Factors; Touch; Tryptophan | 2005 |
Role of substance P in allergic nasal symptoms in rats.
Topics: Animals; Antigens; Cyproheptadine; Dibenzazepines; Dibenzoxepins; Dose-Response Relationship, Drug; Electroencephalography; Histamine H1 Antagonists; Hypersensitivity; Imidazoles; Male; Neurokinin-1 Receptor Antagonists; Olopatadine Hydrochloride; Rats; Rats, Wistar; Sneezing; Substance P; Tryptophan | 2006 |
Effects of KP-496, a novel dual antagonist for leukotriene D4 and thromboxane A2 receptors, on contractions induced by various agonists in the guinea pig trachea.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetates; Acetylcholine; Albuterol; Animals; Atropine; Benzoquinones; Carbachol; Chromones; Cyclopropanes; Dinoprost; Drug Evaluation, Preclinical; Guinea Pigs; Heptanoic Acids; Histamine; In Vitro Techniques; Indoles; Indomethacin; Ketanserin; Ketotifen; Leukotriene Antagonists; Leukotriene D4; Male; Muscle Contraction; Muscle, Smooth; Phenylcarbamates; Powders; Procaterol; Prostaglandin Antagonists; Prostaglandin D2; Quinolines; Receptors, Thromboxane A2, Prostaglandin H2; Serotonin; Substance P; Sulfides; Sulfonamides; Tosyl Compounds; Trachea; Tryptophan | 2006 |
Paradoxical effect of salbutamol in a model of acute organophosphates intoxication in guinea pigs: role of substance P release.
Topics: Albuterol; Animals; Calcium; Cholinesterase Inhibitors; Colforsin; Diamines; Guinea Pigs; Lung; Male; Muscle Contraction; omega-Conotoxins; Parathion; Physostigmine; Pirenzepine; Plethysmography, Whole Body; Substance P; Tetrodotoxin; Tryptophan | 2007 |
Neurokinin-1 receptors located in human retinoblastoma cell lines: antitumor action of its antagonist, L-732,138.
Topics: Apoptosis; Blotting, Western; Cell Count; Cell Proliferation; Child, Preschool; Dose-Response Relationship, Drug; Humans; Immunoenzyme Techniques; Neurokinin-1 Receptor Antagonists; Piperidines; Receptors, Neurokinin-1; Retinal Neoplasms; Retinoblastoma; Stereoisomerism; Substance P; Tryptophan; Tumor Cells, Cultured | 2007 |
NK-1 receptor antagonists induce apoptosis and counteract substance P-related mitogenesis in human laryngeal cancer cell line HEp-2.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Humans; Laryngeal Neoplasms; Mitosis; Neurokinin-1 Receptor Antagonists; Piperidines; Receptors, Neurokinin-1; Substance P; Tryptophan | 2008 |
Substance P stimulates CFTR-dependent fluid secretion by mouse tracheal submucosal glands.
Topics: Animals; Benzoates; Capsaicin; Clotrimazole; Cystic Fibrosis Transmembrane Conductance Regulator; Exocrine Glands; Irritants; Mice; Mice, Inbred CFTR; Mucus; Neurokinin-1 Receptor Antagonists; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Receptors, Neurokinin-1; Respiratory Mucosa; Substance P; Thiazolidines; Time Factors; Trachea; Tryptophan | 2008 |
Substance P is associated with the development of brain edema and functional deficits after traumatic brain injury.
Topics: Animals; Brain Edema; Brain Injuries; Capillary Permeability; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Magnetic Resonance Imaging; Male; Microscopy, Confocal; Microscopy, Immunoelectron; Motor Activity; Neurokinin-1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Substance P; Tryptophan | 2009 |
Selective nasal allergen provocation induces substance P-mediated bronchial hyperresponsiveness.
Topics: Administration, Inhalation; Allergens; Animals; Asthma; Bronchi; Bronchial Hyperreactivity; Immunization; Leukocyte Count; Male; Methacholine Chloride; Mice; Mice, Inbred BALB C; Nasal Provocation Tests; Neurokinin-1 Receptor Antagonists; Ovalbumin; Receptors, Neurokinin-1; Substance P; Tryptophan; Up-Regulation | 2011 |
Spinal cord mechanisms mediating behavioral hyperalgesia induced by neurokinin-1 tachykinin receptor activation in the rostral ventromedial medulla.
Topics: Animals; Behavior, Animal; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Excitatory Amino Acid Antagonists; Freund's Adjuvant; GABA Agents; Hyperalgesia; In Vitro Techniques; Inflammation; Male; Medulla Oblongata; Membrane Potentials; Microinjections; Muscimol; Ondansetron; Oxazines; Pain Measurement; Pain Threshold; Posterior Horn Cells; Pyridazines; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Neurokinin-1; Serotonin Antagonists; Spinal Cord; Substance P; Tryptophan; Up-Regulation | 2010 |
The NK-1 receptor is expressed in human leukemia and is involved in the antitumor action of aprepitant and other NK-1 receptor antagonists on acute lymphoblastic leukemia cell lines.
Topics: Antineoplastic Agents; Apoptosis; Aprepitant; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Survival; Child; Dose-Response Relationship, Drug; Female; Humans; Inhibitory Concentration 50; Morpholines; Neurokinin-1 Receptor Antagonists; Piperidines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Real-Time Polymerase Chain Reaction; Receptors, Neurokinin-1; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Messenger; Substance P; Tryptophan | 2012 |
Characterizing the role of the neuropeptide substance P in experimental subarachnoid hemorrhage.
Topics: Animals; Brain Edema; Intracranial Hypertension; Male; Rats; Rats, Sprague-Dawley; Subarachnoid Hemorrhage; Substance P; Tryptophan | 2011 |
A substance P antagonist improves outcome when administered 4 h after onset of ischaemic stroke.
Topics: Animals; Blood-Brain Barrier; Brain Edema; Brain Ischemia; Disease Models, Animal; Drug Administration Schedule; Infarction, Middle Cerebral Artery; Male; Neurokinin-1 Receptor Antagonists; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Recovery of Function; Substance P; Time Factors; Tryptophan | 2011 |
Substance P induces adverse myocardial remodelling via a mechanism involving cardiac mast cells.
Topics: Animals; Apoptosis; Cell Degranulation; Collagen; Disease Models, Animal; Heart Failure; In Situ Nick-End Labeling; Male; Mast Cells; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Neurokinin A; Neurokinin-1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Substance P; Time Factors; Tryptophan; Tumor Necrosis Factor-alpha; Ultrasonography; Ventricular Remodeling | 2011 |
Pharmacological characteristics of endokinin C/D-derived peptides in nociceptive and inflammatory processing in rats.
Topics: Amino Acid Sequence; Amino Acids; Analgesics; Animals; Anti-Inflammatory Agents; Behavior, Animal; Carrageenan; Formaldehyde; Humans; Hyperalgesia; Immunohistochemistry; Inflammation; Injections, Subcutaneous; Male; Nociceptive Pain; Pain Measurement; Peptide Fragments; Posterior Horn Cells; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Substance P; Tachykinins; Time Factors; Tryptophan | 2011 |
Treatment with a substance P receptor antagonist is neuroprotective in the intrastriatal 6-hydroxydopamine model of early Parkinson's disease.
Topics: Animals; Anti-Inflammatory Agents; Blood-Brain Barrier; Cells; Dopaminergic Neurons; Inflammation; Male; Motor Activity; Neurokinin-1 Receptor Antagonists; Neuroprotective Agents; Oxidopamine; Parkinson Disease, Secondary; Piperidines; Rats; Rats, Sprague-Dawley; Rotarod Performance Test; Substance P; Substantia Nigra; Tryptophan | 2012 |
Substance P-induced changes in cell genesis following diffuse traumatic brain injury.
Topics: Animals; Brain Injuries; Cell Differentiation; Male; Microglia; Neurogenesis; Neurokinin-1 Receptor Antagonists; Neuroprotective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Substance P; Tryptophan | 2012 |
A substance P antagonist improves outcome in female Sprague Dawley rats following diffuse traumatic brain injury.
Topics: Animals; Brain Injuries; Disease Models, Animal; Female; Motor Activity; Rats; Rats, Sprague-Dawley; Substance P; Tryptophan | 2012 |
Role of tachykinins and neurokinin receptor subtypes in the regulation of motility of the forestomach and abomasum in conscious sheep.
Topics: Abomasum; Animals; Benzamides; Gastrointestinal Motility; Injections, Intravenous; Kinetics; Male; Muscle Contraction; Neurokinin A; Omasum; Piperidines; Receptors, Neurokinin-2; Rumen; Sheep; Substance P; Tachykinins; Tryptophan | 2013 |
The substance P/neurokinin-1 receptor system in lung cancer: focus on the antitumor action of neurokinin-1 receptor antagonists.
Topics: Antineoplastic Agents; Apoptosis; Aprepitant; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Morpholines; Neurokinin-1 Receptor Antagonists; Piperidines; Receptors, Neurokinin-1; Structure-Activity Relationship; Substance P; Tryptophan; Tumor Cells, Cultured | 2012 |
The microbiota and the gut-brain axis: insights from the temporal and spatial mucosal alterations during colonisation of the germfree mouse intestine.
Topics: Animals; Bacteria; Brain; Colon; Enzyme Activation; Feces; Gene Expression Profiling; Gene Expression Regulation; Germ-Free Life; Homeostasis; Immunohistochemistry; Indoleamine-Pyrrole 2,3,-Dioxygenase; Intestinal Mucosa; Intestine, Small; Kynuramine; Male; Metagenome; Mice; Mice, Inbred C57BL; Neurons; Stress, Physiological; Substance P; Synaptic Transmission; Time Factors; Tryptophan | 2012 |
Acute colitis induces neurokinin 1 receptor internalization in the rat lumbosacral spinal cord.
Topics: Acute Disease; Animals; Colitis; Colon; Formaldehyde; Gene Expression; Lumbosacral Region; Male; Neurokinin-1 Receptor Antagonists; Neurons; Nociception; Nociceptive Pain; Protein Transport; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Spinal Cord; Substance P; Tryptophan | 2013 |
NK1 receptor blockade is ineffective in improving outcome following a balloon compression model of spinal cord injury.
Topics: Animals; Blood-Brain Barrier; Disease Models, Animal; Inflammation; Neurokinin-1 Receptor Antagonists; Protease Inhibitors; Rabbits; Receptors, Neurokinin-1; Spinal Cord Compression; Substance P; Tryptophan | 2014 |
The neurokinin-1 receptor antagonist aprepitant is a promising candidate for the treatment of breast cancer.
Topics: Antineoplastic Agents; Aprepitant; Breast Neoplasms; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; MCF-7 Cells; Morpholines; Neurokinin-1 Receptor Antagonists; Piperidines; Receptors, Neurokinin-1; Substance P; Tryptophan | 2014 |
Antinociceptive effects of endomorphin-2: suppression of substance P release in the inflammatory pain model rat.
Topics: Animals; Arthritis, Experimental; Chronic Pain; Ganglia, Spinal; Hyperalgesia; Injections, Spinal; Male; Microdialysis; Microscopy, Electron; Neurokinin-1 Receptor Antagonists; Neurons, Afferent; Nociception; Oligopeptides; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Receptors, Presynaptic; Spinal Cord; Spinal Cord Dorsal Horn; Stress, Mechanical; Substance P; Tryptophan | 2015 |
N-acetyl-l-tryptophan, but not N-acetyl-d-tryptophan, rescues neuronal cell death in models of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Apoptosis; Caspases; Cell Line; Cytochromes c; Drug Evaluation, Preclinical; Hybrid Cells; Interleukin-1beta; Mice; Mitochondria; Motor Neurons; Neurokinin-1 Receptor Antagonists; Neuroprotective Agents; Proteasome Endopeptidase Complex; Receptors, Neurokinin-1; Stereoisomerism; Substance P; Tryptophan | 2015 |
New ligands of the ghrelin receptor based on the 1,2,4-triazole scaffold by introduction of a second chiral center.
Topics: Fluorescence Resonance Energy Transfer; Indoles; Inhibitory Concentration 50; Ligands; Receptors, Ghrelin; Structure-Activity Relationship; Substance P; Triazoles; Tryptophan | 2016 |
Correcting a widespread error: Neuroprotectant N-acetyl-L-tryptophan does not bind to the neurokinin-1 receptor.
Topics: Acetylation; Animals; Neuroprotection; Neuroprotective Agents; Rats; Receptors, Neurokinin-1; Substance P; Tryptophan | 2022 |